Previously Treated with EN3835

BIOLOGICAL2 trials

Sponsors

Endo Pharmaceuticals

Conditions

Edematous Fibrosclerotic Panniculopathy

Unknown Phase

Durability and Safety of EN3835 in the Treatment of EFP (Cellulite) in Women

CompletedNCT03893890

Endo PharmaceuticalsEdematous Fibrosclerotic Panniculopathy

Start: 2019-03-28End: 2019-06-25Updated: 2019-07-19

Long-term Durability Study of Collagenase Clostridium Histolyticum (CCH)

CompletedNCT04381117

Endo PharmaceuticalsEdematous Fibrosclerotic Panniculopathy

Start: 2020-05-06End: 2020-06-22Updated: 2024-01-02